Follow us on Bluesky
Bluesky · Hashtag

#$MRK

21
posts · 30d
9
users
1
posts / day
2.3
posts / user
+ 100% vs last week

#$MRK is an active hashtag on Bluesky. In the last 30 days, 9 people shared 21 posts with it — around 1 a day. Activity is up 100% versus the previous week, peaking on Aug 26 with 11 posts.

#$MRK posts per day (last 30 days)

Related tags

Tags most often used together with #$MRK.

#TNBC 9 #$GILD 9 #Pembrolizumab 6 #$LLY 5 #Gilead 5

Posts with #$MRK

Carl Quintanilla
@carlquintanilla.bsky.social
about 1 month ago
Merck surpassing Caterpillar as the Dow’s second-best stock of the year was not on many people’s bingo card. $MRK
6 22 186
Metro North Capital
@metronorthcapital.bsky.social
about 1 month ago
Mkt thinks the $MRNA / $MRK clinical trial results are worth a cool $70bn. Impressive
1 1 16
David Shaywitz
@dshaywitz.bsky.social
5 days ago
In today's @wsj.com, my review of the final installment of Barry Werth's "Drug Wars" trilogy - surprisingly, a prequel, describing the evolution of biopharma during the mid 20th century, describing the envt (thru lens of $MRK) into which $VRTX was later born. www.wsj.com/arts-culture...
‘The Age of Cures’ Review: What the Pharmacist Ordered

www.wsj.com

‘The Age of Cures’ Review: What the Pharmacist Ordered

The 20th-century advance in American pharmaceutical science was driven by a cohort of devoted researchers working with ambitious drug companies.
0 1 2
midgardfinance.com
@midgardfinance.com
about 1 month ago
🇺🇸 Moderna and Merck's cancer vaccine cleared Phase 3 in melanoma this week, and there is no pathogen anywhere in it. It teaches T cells to recognise up to 34 mutations found only in that patient's own tumour. One batch treats one person. $MRNA $MRK
Flow diagram in six numbered boxes, three across and two down, each with a small line icon, titled "Teaching T cells a target", explaining how an individualised neoantigen cancer therapy works inside the body. One, Inject, syringe icon: an mRNA shot coding for up to 34 mutations from that tumour. Two, Read, cell icon: immune cells take it up and make those mutant proteins. Three, Display, flag icon: in a lymph node they show fragments on their surface, like flags. Four, Train, dividing-cells icon: nothing taught T cells to ignore these flags, so those that fit multiply. Five, Hunt, target icon: only the tumour carries the mutations, so it alone keeps the flag flying. Six, Unblock, open-padlock icon: Keytruda stops the tumour switching those T cells off.
Flow diagram in four numbered boxes, two across and two down, each with a small line icon, titled "One patient, one vaccine", explaining how an individualised neoantigen cancer therapy is manufactured. One, Resect, DNA helix icon: the tumour comes out and is sequenced against the patient's own healthy DNA. Two, Select, funnel icon: up to 34 mutations found only in that tumour, matched to the patient's immune type. Three, Build, vial icon: all 34 encoded on one mRNA strand, wrapped in a nanoparticle, taking six to eight weeks. Four, Dose, calendar icon with nine dots: one batch, one patient, nobody else can use it, and nine doses follow, one every three weeks.
0 1 3
@bioclouseau.bsky.social
about 2 months ago
$MRK TL1A met its primary endpoint in a P2 hidradenitis suppurativa trial. Failed SSc-ILD P2
0 0 3
Robert Lee
@roberee.bsky.social
about 1 month ago
$MRNA $MRK A win for humanity. "The combination regimen met the main study goal of significantly extending the time patients lived without their melanoma returning, compared with Keytruda alone, and also reduced the risk of the cancer spreading to distant parts of the body."
Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

www.cnbc.com

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
1 0 2
NOTRELOAD AI
@notreload.bsky.social
about 1 month ago
$MRK and $MRNA personalized mRNA vaccine with Keytruda reduced melanoma recurrence in a 1,137-patient Phase 3 trial—the first late-stage win for an mRNA cancer vaccine. notreload.xyz/xy/merck-mod...
Merck-Moderna mRNA Vaccine Succeeds in Phase 3 Melanoma Trial

notreload.xyz

Merck-Moderna mRNA Vaccine Succeeds in Phase 3 Melanoma Trial

Merck and Moderna’s personalized mRNA vaccine with Keytruda reduced melanoma recurrence in a 1,137-patient Phase 3 trial—the first late-stage win for an mRNA cancer vaccine.
0 1 2

Posts are pulled live from Bluesky and cached briefly. Posts with content labels are hidden.

View all posts on Bluesky

Explore trending tags

#art #oc #nsfw #furry #digitalart #fanart #furryart #AI #photography #gay #illustration #fcf
Back to all tags